ATM and renal carcinoma: Since different VHL status in renal carcinoma cells have been shown to affect their drug sensitivity in hypoxic conditions [45,46], we stably reintroduced VHL into 786-O VHL-deficient cells and evaluated their sensitivity to the CK2 and ATM inhibitors under low oxygen concentration (1.5%) (Figure 1C1,C2).